Search

everythinglearnresearchcommunity

for

Search:↓

Dermoscopy improves accuracy in predicting treatment success for androgenetic alopecia with the Regenera® protocol.

Exclamation-mark hairs and yellow dots indicate alopecia areata, while follicular ostia loss and white scarring indicate lichen planopilaris and discoid lupus erythematosus.

Early diagnosis and thorough evaluation are crucial for better outcomes in alopecic sarcoidosis.

Hair loss due to scarring can be treated by reducing inflammation, removing scar tissue, and transplanting hair. The Follicular Unit Extraction technique is effective but requires skill and time. Future focus should be on scar-less healing methods.

Trichoscopy is an effective, noninvasive method for early diagnosis of Female Pattern Hair Loss.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

Androgenetic alopecia is a long-term, immune-related disorder that starts during puberty due to androgen secretion, and it might be improved with iron tablets, platelet transfusion, and anti-inflammation therapy.

Uterine leiomyomas don't significantly change gene expression in the scalp of people with Central Centrifugal Cicatricial Alopecia.

Allergic rhinitis increases hair loss risk, but antihistamines can reduce it.

New regenerative treatments show promise in improving hair growth for androgenetic alopecia.

Interest in new and personalized treatments for hair loss is growing.

Combined microneedling with minoxidil improves hair growth more than minoxidil alone but may cause mild side effects.

Androgenetic alopecia involves immune cell disruptions, especially increased CD4+ T cells around hair follicles.

Accurate diagnosis is crucial for effective treatment of hair loss.

Dermoscopy is a useful, low-cost method for diagnosing various types of hair loss disorders known as Cicatricial Alopecia.

A new method using fat tissue cells may help treat hair loss.

Spironolactone is effective for treating female hair loss, with new treatments like clascoterone showing promise.

Periplaneta americana extract promotes hair growth and is safe for treating hair loss.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Metal nanoparticles show promise for treating hair loss but need more research to ensure safety.

The new delivery method for finasteride using nanoparticles may improve hair growth without skin issues.

PRP shows promise for treating mild alopecia areata but needs more research for cicatricial alopecias.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

The LncRNA AC010789.1 slows down hair loss by promoting hair follicle growth and interacting with miR-21 and the Wnt/β-catenin pathway.

Acupuncture may be a safe and cost-effective treatment for Seborrheic alopecia.

Stem cell technology may improve hair loss treatments by providing more effective and personalized options.

New treatments for alopecia areata show promise but need ongoing use and have infection risks.

Androgenetic alopecia is linked to factors like age, family hair loss history, diet, and health conditions.

GLP-1 receptor agonists for weight loss may cause hair loss, especially in women.

Specific miRNA profiles can help diagnose and treat alopecia areata.